68009-06-3

Basic information

• Product Name: Imidazo[1,2-a]quinoxalin-4-amine, N-cyclohexyl-
• CAS NO: 68009-06-3
• Molecular Formula: C16H18N4
• Molecular Weight: 266.346
• Mol File: 68009-06-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Imidazo[1,2-a]quinoxalin-4-amine, N-cyclohexyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,2-a]quinoxalin-4-amine, N-cyclohexyl-(68009-06-3)
• EPA Substance Registry System: Imidazo[1,2-a]quinoxalin-4-amine, N-cyclohexyl-(68009-06-3)

Safety Data

• Hazardous Substances Data: 68009-06-3(Hazardous Substances Data)

Upstream product

• 108-91-8 cyclohexylamine 
• 191349-69-6 4-chloroimidazo[1,2-a]quinoxaline 
• 191349-68-5 2-chloro-3-(2,2-dimethoxyethylamino)quinoxaline 
• 133307-45-6 imidazo[1,2-a]quinoxaline-4-(5H)-one 

Relevant articles and documents

Imidazo[1,2-a]quinoxalin-4-amines active as adenosine antagonists, process for their preparation and pharmaceutical compositions thereof

PCT No. PCT/IB96/01291 Sec. 371 Date May 12, 1998 Sec. 102(e) Date May 12, 1998 PCT Filed Nov. 22, 1996 PCT Pub. No. WO97/19079 PCT Pub. Date May 29, 1997Imidazo[1,2-a]quinoxalin-4-amines derivatives of formula (I) are described, and salt thereof active as adenosine antagonists and a process for their preparation and pharmaceutical compositions containing them as therapeutically active compounds for psychiatric and neurological disorders of the central nervous system.

Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines

A method for treating a fungal infection in mammals which comprises administering to said mammals having a fungal infection a therapeutically effective amount of a 4-(substituted phenyl)imidazo[1,2-a]quinoxaline.

1-(2-Acylaminophenyl)imidazoles

A 1-(2-acylaminophenyl)imidazole of formula: STR1 wherein R5 is hydrogen or an aliphatic, cycloaliphatic, phenyl, substituted phenyl, fused bicyclic aryl or monocyclic aryl substituted aliphatic group bonded to the carbonyl carbon through a carbon-to-carbon linkage. The compounds are useful as intermediates in the preparation of 4-substituted imidazo[1,2-a]quinoxalines.